Back to Treatments

Treatment

Carfilzomib

1
Conditions
219
Trials
10K
Participants
48%
Average Safety

Condition Evidence

Multiple myeloma

219 trials · 10K participants

90% effectiveness · 48% safety
Carfilzomib | DFDA